Davide Pareyson, MD, is a Clinical Neurologist working at the Fondazione IRCCS Istituto Neurologico C.Besta (FINCB) of Milan, Italy, where he is Head of the Functional Department of Rare Neurological Diseases and Chief of the Simple Dept. Unit of “Rare Neurological Diseases of Adulthood”. He graduated in Medicine at the Milan University and has a Board in Neurology and in Clinical Neurophysiology. His main interest is clinical research on hereditary and acquired peripheral neuropathies and motor neuronopathies, inherited neurological disorders, rare diseases. He performed studies on phenotype-genotype correlation, clinical findings, electrophysiology, neuropathology of hereditary neuropathies (particularly Charcot-Marie-Tooth disease – CMT – and related neuropathies, but also amyloid neuropathy) and other neurogenetic disorders including spinal and bulbar muscle atrophy, hereditary spastic paraplegias, hereditary ataxias, genetic leukodystrophies. He has been working on the development of outcome measures for hereditary neuropathies and other rare diseases and has coordinated and participated in clinical trials and natural history studies in inherited and acquired neuropathies. He is the Coordinator of the National Registries of Charcot-Marie-Tooth disease and of Spino-Bulbar Muscular Atrophy.
“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern“